Workflow
Wayzim(688211)
icon
Search documents
中科微至:计提资产减值准备合计减少第三季度合并利润总额4133.39万元
Mei Ri Jing Ji Xin Wen· 2025-10-30 10:41
Group 1 - The company Zhongke Weizhi (SH 688211) announced a provision for impairment losses, which will reduce its consolidated profit for the third quarter of 2025 by 41.33 million yuan [1] - For the first half of 2025, the revenue composition of Zhongke Weizhi is as follows: total integrated sorting systems account for 42.99%, cross-belt sorting systems account for 14.93%, narrow-band machine systems account for 11.53%, intelligent warehousing systems account for 8.81%, and other businesses account for 7.51% [1] - As of the report date, the market capitalization of Zhongke Weizhi is 4.2 billion yuan [2]
中科微至:第三季度净亏损1.17亿元
Ge Long Hui A P P· 2025-10-30 10:37
Group 1 - The core point of the article is that Zhongke Weizhi reported a significant decline in revenue and a net loss for the third quarter and the first three quarters of the year [1] Group 2 - In the third quarter, the company's revenue was 225 million yuan, representing a year-on-year decrease of 50.83% [1] - The net profit for the third quarter was a loss of 117 million yuan [1] - For the first three quarters, the total revenue was 1.227 billion yuan, down 31.86% year-on-year [1] - The net profit for the first three quarters was a loss of 180 million yuan [1]
中科微至(688211) - 2025 Q3 - 季度财报
2025-10-30 10:25
Financial Performance - The company's operating revenue for the third quarter was ¥224,986,946.62, a decrease of 50.83% compared to the same period last year[3]. - The net profit attributable to shareholders was -¥117,165,301.92, with a year-to-date net profit of -¥179,646,146.28, indicating significant losses[3]. - The company experienced a year-to-date revenue decline of 31.86%, primarily due to reduced project acceptance[9]. - Total revenue for the first three quarters of 2025 was CNY 1,227,032,177.75, a decrease of 31.8% compared to CNY 1,800,821,114.20 in the same period of 2024[17]. - The net profit for the first three quarters of 2025 was a loss of CNY 179,646,156.73, compared to a loss of CNY 11,891,619.65 in the same period of 2024, indicating a significant increase in losses[18]. - The basic and diluted earnings per share were both -¥0.92, reflecting ongoing financial challenges[3]. - The company reported a basic and diluted earnings per share of CNY -1.41 for the first three quarters of 2025, compared to CNY -0.09 in the same period of 2024[18]. - Operating profit for the first three quarters of 2025 was a loss of CNY 116,018,049.31, compared to a profit of CNY 4,695,971.79 in the first three quarters of 2024[25]. - Net profit for the first three quarters of 2025 was a loss of CNY 125,339,222.23, compared to a profit of CNY 13,859,980.73 in the same period of 2024[25]. Cash Flow - The net cash flow from operating activities was ¥4,086,091.09, down 98.00% year-on-year, reflecting increased cash payments for goods and services[3][9]. - Cash flow from operating activities generated a net amount of CNY 60,902,686.07 in the first three quarters of 2025, down from CNY 357,726,087.67 in 2024[19]. - Cash flow from investing activities showed a net inflow of CNY 98,942,666.57 in 2025, contrasting with a net outflow of CNY 95,946,093.50 in 2024[20]. - Net cash flow from operating activities was -$422,246,227.60, compared to a positive $191,320,689.64 last year[29]. - Total cash outflow for operating activities was $2,619,865,293.76, compared to $1,649,881,765.92 in the previous period[29]. - Cash paid for purchasing goods and services was $1,754,695,087.65, an increase from $1,274,854,879.57[29]. Assets and Liabilities - Total assets increased by 12.47% to ¥6,962,848,849.26 compared to the end of the previous year[4]. - The total assets increased to CNY 6,962,848,849.26 in 2025 from CNY 6,191,104,639.26 in 2024, marking a growth of 12.5%[15]. - Total liabilities rose to CNY 3,585,478,290.44 in 2025, compared to CNY 2,646,792,472.59 in 2024, reflecting an increase of 35.4%[15]. - Total liabilities as of September 30, 2025, were CNY 2,904,264,162.92, compared to CNY 2,072,267,653.37 as of December 31, 2024[23]. - Current assets totaled CNY 4,905,770,582.74 as of September 30, 2025, up from CNY 4,160,677,379.54 as of December 31, 2024[22]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 10,458[11]. - The largest shareholder, Wuxi Weiziyuan Investment, holds 27 million shares, representing 20.52% of total shares[11]. - The company has not disclosed any changes in the top 10 shareholders due to margin trading activities[13]. - The company has not identified any related party relationships among the other shareholders listed[12]. Research and Development - Research and development expenses totaled ¥36,704,821.89, accounting for 16.31% of operating revenue, an increase of 8.56 percentage points year-on-year[4]. - Research and development expenses for the first three quarters of 2025 were CNY 100,471,481.47, a decrease from CNY 116,337,390.14 in 2024, indicating a reduction of 13.6%[17]. - The company reported a decrease in research and development expenses to CNY 96,912,660.30 in the first three quarters of 2025, down from CNY 107,112,558.06 in the same period of 2024[25]. Inventory and Receivables - The total inventory increased to approximately ¥2.18 billion, compared to ¥1.70 billion, marking a rise of 28.1%[14]. - The company reported an increase in accounts receivable to approximately ¥547.19 million from ¥499.27 million, an increase of 9.6%[14]. - The total amount of long-term receivables increased to approximately ¥42.50 million from ¥37.70 million, a growth of 12.3%[14]. - Inventory as of September 30, 2025, was CNY 1,973,076,140.84, an increase of 26.4% from CNY 1,558,780,974.66 as of December 31, 2024[22].
中科微至(688211) - 中科微至关于2025年第三季度计提减值准备的公告
2025-10-30 10:22
证券代码:688211 证券简称:中科微至 公告编号:2025-047 中科微至科技股份有限公司 关于 2025 年第三季度计提减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、计提资产减值准备情况的概述 中科微至科技股份有限公司(以下简称"公司") 根据《企业会计准则》以及公 司会计政策、会计估计的相关规定,为了客观、公允地反映公司截至 2025 年 9 月 30 日的财务状况,本着谨慎性原则,对合并报表范围内可能发生信用及资产 减值损失的有关资产计提资产减值准备。2025 年第三季度,公司确认信用减值 损失和资产减值损失共计 4,133.39 万元,具体情况如下表所示: 单位:万元 注:合计数与分项有差异系四舍五入尾差导致 | 序号 | 项目 | 2025 年第三季 度计提金额 | 备注 | | --- | --- | --- | --- | | 1 | 资产减值损失 | 2,759.42 | 存货跌价准备、合同资产、其他 非流动资产 | | 2 | 信用减值损失 | 1,373.97 | 应收账款、 ...
中科微至:第三季度净利润亏损1.17亿元
Xin Lang Cai Jing· 2025-10-30 10:09
Core Points - The company reported a third-quarter revenue of 225 million yuan, representing a year-on-year decline of 50.83% [1] - The net profit for the third quarter was a loss of 117 million yuan [1] - For the first three quarters, the total revenue was 1.227 billion yuan, down 31.86% year-on-year [1] - The net profit for the first three quarters was a loss of 180 million yuan [1]
中科微至(688211) - 中科微至2024年限制性股票激励计划第一次预留授予部分第一个归属期符合归属条件的公告
2025-10-24 09:33
关于 2024 年限制性股票激励计划第一次预留授予部 分第一个归属期符合归属条件的公告 证券代码:688211 证券简称:中科微至 公告编号:2025-045 中科微至科技股份有限公司 限制性股票拟归属数量:0.636 万股。 归属股票来源:中科微至科技股份有限公司(以下简称"公司")从二级 市场回购的公司 A 股普通股股票及/或向激励对象定向发行的公司 A 股普通股股 票。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 一、 本次股权激励计划批准及实施情况 (一) 公司 2024 年限制性股票激励计划(以下简称"本激励计划")的主 要内容 1、股权激励方式:第二类限制性股票。 2、授予数量:实际授予的限制性股票总量为 82.30 万股,约占《中科微至 科技股份有限公司 2024 年限制性股票激励计划(草案)》(以下简称"《激励计划 (草案)》")公告时公司股本总额的 0.63%。其中,首次授予 76.38 万股,占《激 励计划(草案)》公告时公司股本总额的 0.58%;第一次预留授予 3.18 万股,占 ...
中科微至(688211) - 北京植德律师事务所关于中科微至2024年限制性股票激励计划第一次预留授予部分第一个归属期符合归属条件相关事项的法律意见书
2025-10-24 09:33
北京植德律师事务所 关于中科微至科技股份有限公司 2024 年限制性股票激励计划 第一次预留授予部分第一个归属期符合归属条件 相关事项的法律意见书 植德(证)证字[2024]011-6 号 二〇二五年十月 北京植德律师事务所 Merits & Tree Law Offices 北京市东城区东直门南大街1号来福士中心办公楼 5 层 邮编:100007 5th Floor, Raffles City Beijing Offices Tower, No.1 Dongzhimen South Street,Dongcheng District, Beijing 100007 P.R.C. 电话/Tel: 010-56500900 传真/Fax: 010-56500999 www.meritsandtree.com 北京植德律师事务所 关于中科微至科技股份有限公司 2024 年限制性股票激励计划 第一次预留授予部分第一个归属期符合归属条件 相关事项的法律意见书 植德(证)证字[2024]011-6 号 致:中科微至科技股份有限公司 根据本所与公司签署的《律师服务协议书》,本所接受公司的委托,担任公 司本次股权激励的专项 ...
中科微至(688211) - 中信证券股份有限公司关于中科微至科技股份有限公司终止部分募投项目并将剩余募集资金继续存放募集资金专户管理的核查意见
2025-10-24 09:33
经上海证券交易所科创板股票上市委员会审核同意,并根据中国证券监督管 理委员会出具证监许可〔2021〕2451 号同意注册文件,公司首次向社会公开发 行人民币普通股(A 股)股票 3,300.00 万股,每股发行价格为人民币 90.20 元, 募集资金总额为 297,660.00 万元,扣除各项发行费用后的实际募集资金净额为 274,855.77 万元,实际到账金额为 275,870.43 万元,上述募集资金到位情况已经 毕马威华振会计师事务所(特殊普通合伙)审验,出具了毕马威华振验字第 2101048 号验资报告。 为规范公司募集资金管理和使用,保护投资者权益,公司设立了募集资金专 项账户。上述募集资金到账后,已全部存放于募集资金专项账户内,公司已与保 荐机构及存储募集资金的商业银行签订了募集资金专户监管协议。 二、募集资金投资项目使用情况 中信证券股份有限公司 关于中科微至科技股份有限公司 终止部分募投项目并将剩余募集资金 继续存放募集资金专户管理的核查意见 中信证券股份有限公司(以下简称"中信证券"或"保荐机构")作为中科微至 科技股份有限公司(以下简称"中科微至"、"公司")首次公开发行股票并在科创 板 ...
中科微至(688211) - 中信证券股份有限公司关于中科微至科技股份有限公司部分募投项目延期的核查意见
2025-10-24 09:33
中信证券股份有限公司 关于中科微至科技股份有限公司 部分募投项目延期的核查意见 中信证券股份有限公司(以下简称"中信证券"或"保荐机构")作为中科微至 科技股份有限公司(以下简称"中科微至"、"公司")首次公开发行股票并在科创 板上市的保荐机构,根据《证券发行上市保荐业务管理办法》《上市公司募集资 金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上 市公司自律监管指引第 1 号——规范运作》《上海证券交易所上市公司自律监管 指引第 11 号——持续督导》等有关规定,对公司部分募投项目延期事项进行了 核查,核查情况及核查意见如下: 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意中科微至智能制造科技江苏 股份有限公司首次公开发行股票注册的批复》(证监许可〔2021〕2451 号),公 司向社会公开发行人民币普通股 3,300.00 万股,每股发行价格为人民币 90.20 元, 募集资金总额为人民币 2,976,600,000.00 元,扣除发行费用后实际募集资金净额 为人民币 2,748,557,661. 34 元,其中,超募资金金额为人民币 1,409,128,589.3 ...
中科微至(688211) - 中科微至关于终止部分募投项目并将剩余募集资金继续存放募集资金专户管理的公告
2025-10-24 09:31
证券代码:688211 证券简称:中科微至 公告编号:2025-043 中科微至科技股份有限公司 关于终止部分募投项目并将剩余募集资金继续存放 募集资金专户管理的公告 二、 募集资金投资项目使用情况 截至 2025 年 8 月 31 日,根据公司《首次公开发行股票并在科创板上市招股 说明书》的募集资金项目及募集资金使用进展的情况如下: 注:公司于 2023 年 10 月 24 日召开第二届董事会第四次会议及第二届监事会第四次会 议,于 2023 年 11 月 10 日召开 2023 年第一次临时股东大会,审议通过了《关于南陵制造基 地数字化车间建设项目结项并将节余募集资金永久补充流动资金的议案》,同意将"南陵制造 基地数字化车间建设项目"予以结项,并将节余募集资金 8,225.35 万元(实际金额以资金转 出当日募集资金专户余额为准)用于永久补充公司流动资金。实际补充流动的金额为节余募 集资金及其对应利息收入合计 8,274.74 万元。 三、 本次募投项目终止情况说明 (一) 拟终止募投项目情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完 ...